Published in PLoS One on October 06, 2015
Dual-phase amyloid PET: hitting two birds with one stone. Eur J Nucl Med Mol Imaging (2016) 0.81
Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment. Eur J Nucl Med Mol Imaging (2016) 0.78
Comparability of [(18)F]THK5317 and [(11)C]PIB blood flow proxy images with [(18)F]FDG positron emission tomography in Alzheimer's disease. J Cereb Blood Flow Metab (2016) 0.77
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal (2007) 13.54
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab (2005) 6.25
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Diaschisis. Stroke (1986) 2.94
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86
Diaschisis: past, present, future. Brain (2014) 2.79
Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry (2011) 2.32
Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med (1999) 2.30
Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr (1990) 2.09
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol (2013) 1.75
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging (2012) 1.56
Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med (2004) 1.56
The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain (1998) 1.49
Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage (2003) 1.33
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
11C-DTBZ and 18F-FDG PET measures in differentiating dementias. J Nucl Med (2005) 1.24
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage Clin (2013) 1.21
Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches. Neuroimage (2007) 1.09
Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke (1988) 0.99
Cerebral amyloid angiopathy and dementia. Panminerva Med (2004) 0.99
Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med (2009) 0.95
Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med (2011) 0.94
Association of hypometabolism and amyloid levels in aging, normal subjects. Neurology (2014) 0.92
Delayed intrahemispheric remote hypometabolism. Correlations with early recovery after stroke. Cerebrovasc Dis (2000) 0.91
Amyloid PET imaging: applications beyond Alzheimer's disease. Clin Transl Imaging (2015) 0.88
Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. J Cereb Blood Flow Metab (2014) 0.88
The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochim Biophys Acta (2011) 0.85
Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia. J Alzheimers Dis (2013) 0.85
Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med (2014) 0.84
Nuclear medicine in cerebrovascular disease. Semin Nucl Med (2012) 0.81
[An autopsy case of senile dementia suspected to be influenced by cerebral amyloid angiopathy with multiple cortical microinfarcts]. Rinsho Shinkeigaku (2010) 0.76